HIV Drugs Global Market Report 2022 – Yahoo Finance

Kevin Heal and Stephen Bigger break down potential benefits of rate hikes on financial stocks Wed, March 9 at 2 p.m. ET.
Major players in the HIV drugs market are ViiV Healthcare, Gilead Sciences, Merck & Co. , Inc. , Bristol-Myers Squibb Company, Janssen (Johnson&Johnson), F. HOFFMANN-LA ROCHE LTD, Boehringer Ingelheim (C.
New York, March 04, 2022 (GLOBE NEWSWIRE) — announces the release of the report "HIV Drugs Global Market Report 2022" –
H. Boehringer Sohn AG & Ko. KG), AbbVie, Inc., GlaxoSmithKline plc., Mylan Pharmaceuticals, Pfizer, TEVA PHARMACEUTICAL INDUSTRIES LTD., Hetero Drugs, Daiichi Sankyo, Emcure, AstraZeneca, CIPLA, Alexion Pharmaceuticals, Shionogi, Theratechnologies and Abbott Laboratories Inc.

The global HIV drugs market is expected to grow from $31.23 billion in 2021 to $33.39 billion in 2022 at a compound annual growth rate (CAGR) of 6.9%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $40.32 billion in 2026 at a CAGR of 4.8%.

The HIV drugs market consists of sales of Human Immunodeficiency Virus (HIV) drugs used for the treatment of HIV infection/AIDS. The market consists of revenue generated by the antiretroviral drug companies manufacturing the anti-retroviral drugs such as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry and fusion inhibitors, integrase inhibitors, and protease inhibitors (PIs) for the treatment of HIV infection.

The main types of HIV drugs are nucleoside reverse transcriptase inhibitors (NRT’s), non- nucleoside reverse transcriptase inhibitors (NNRT’s), protease inhibitors, integrate inhibitors, fusion inhibitors, chemokine receptor inhibitors and others.Nucleoside reverse transcriptase inhibitors (NRTIs) are structural nucleoside analogues of DNA nucleotides that inhibit HIV-1 RT and viral replication by preventing reverse transcription of the HIV genome.

The drugs are administered through oral and parenteral methods that are used by hospital pharmacies, retail pharmacies, online pharmacies, and others.

North America was the largest region in the HIV drugs market in 2021.Middle East is expected to be the fargest growing region in the forecast period.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The novel corona virus outbreak has augmented the growth of global HIV drugs market.HIV drugs are repurposed to treat Covid 19 infections.

Currently, several countries are evaluating and using antiretroviral drugs (for instance lopinavir boosted with ritonavir (LPV/r)), for treating corona virus infection.

Increasing awareness among people regarding diagnosis and treatment of HIV disease acts as an important driver for the growth of the HIV drug market.HIV/AIDS is one of the most chronic diseases and the high prevalence of the disease in almost all parts of the world has resulted in an unprecedented awareness regarding the disease.

According to WHO, 26 million people were diagnosed with HIV/AIDS in 2020, whereas, 32.7 million people died of AIDS related illness at the end of 2019. The federal government agencies, and various associations across the globe have introduced many initiatives and education campaigns for community awareness to address HIV prevention, treatment, and care.

Side Effects of HIV Drugs have always been a major challenge in antiretroviral therapy.Antiretroviral drugs are used to treat HIV and AIDS as these drugs help lower viral load, control the growth of the virus, boosts the ability to fight infections, prevent HIV transmission to others and help stop or slow down symptoms.

These drugs come with both short-term side effects (diarrhea, difficulty in sleeping, dizziness, fatigue, headache, muscle pain) and long-term side effects (depression, diabetes, heart disease, insomnia). There are several side effects associated with the therapy, thus impacting the growth of the market.

Antiretroviral drugs market is increasingly implementing multi-class combination products for treatment of anti-retroviral therapy.Combination drugs combine multiple medications into one drug form.

Example for multiclass combination drugs or single-tablet regimens (STRs), include both NRTIs and NNRTIs: doravirine, lamivudine, and tenofovir disoproxil fumarate (Delstrigo).Based on drug class, drugs are segmented into Integrase Inhibitors, Protease Inhibitors, Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and Others.

Multi-class Combination Products is the rising burden of HIV and new drug approval.According to WHO, around 690 000 people died from HIV in 2019.

Many companies are focusing on developing breakthrough products for the treatment through antiretroviral drugs in order to maintain their competitive advantage and penetrate new regional markets.

The countries covered in the HIV drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


It's not news that Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) are the undisputed winners of the race to develop and commercialize a coronavirus vaccine. Pfizer expects to make around $32 billion this year from sales of Comirnaty, whereas Moderna expects roughly $19 billion from sales of Spikevax. As great as the jabs from Pfizer and Moderna are at preventing severe disease, they falter when it comes to preventing people from falling ill and being able to infect others.
Ocugen's stock price plunged Friday after the Food and Drug Administration declined to issue an emergency use authorization for the Malvern biopharmaceutical company's Covid-19 vaccine. In November, Ocugen (NASDAQ: OCGN) filed an application seeking the emergency use authorization for Covaxin to prevent Covid-19 in children ages 2 to 18. Covaxin is a Covid vaccine developed by Bharat Biotech of India.
This pharmaceutical company is growing revenue and profits from drugs it doesn't market or sell.
"We don't know what exactly is going on," Jenna Jameson tells her followers.
Patrick Bafuma is bullish on Legend Biotech (NASDAQ: LEGN) and thinks it might be worth $55 billion by 2027. George Budwell believes his pick, Heron Therapeutics (NASDAQ: HRTX), could jump 1,000% in that time frame. Patrick Bafuma (Legend Biotech): Lost amid the recent market doldrums has been some incredible news.
Elizabeth Hurley is letting the world know that even during her intense recovery, she’s a glowing goddess. On March 3, Hurley posted a couple of stunning photos to her Instagram with the simple caption, “Helllooooo from @vivamayrmariawoerth.” View this post on Instagram A post shared by Elizabeth Hurley (@elizabethhurley1) In the photos, we see Hurley […]
Almost a third of people report at least one ongoing symptom between 6 and 12 months after their coronavirus infection, a survey of 152,000 people in Denmark has found. The study includes one of the largest groups yet of people who were not hospitalised with COVID, and followed them for longer than other major studies, the researchers from Denmark's State Serum Institute (SSI) said. Conducted between September 2020 and April 2021, well before the recent Omicron variant surge, the survey compared the responses of 61,002 people who had tested positive for the coronavirus six, nine or 12 months before with those of 91,878 people who had tested negative.
Having even one drink a day could reduce one's overall brain size over time, according to a study published today in the journal Nature Communications.Why it matters: The study found the greatest risks with heavy drinking, but alcohol consumption was linked to reduced brain volume among far more moderate drinkers. The findings could throw cold water on other studies suggesting that lighter alcohol consumption has no impact on, or may even benefit, the brain.Get market news worthy of your time wi
Going to church and volunteering can help reverse memory problems in people with early signs of dementia, research suggests.
There is a sobering new study about the long-term effects of alcohol on your brain; Bradley Blackburn reports for CBS2.
President Joe Biden had a lot on his plate during his State of the Union speech this week — the Russian invasion of Ukraine, COVID-19 and inflation chief among them — so his brief mention of…
Police said the child had enough fentanyl in his system to kill an adult.
A new study found that baricitinib, a rheumatoid arthritis drug developed by Eli Lilly & Co. and Incyte Corp. , reduced the risk of death among patients who have been hospitalized with severe COVID-19. The new
Crowds of critically ill patients, low oxygen supplies and poor hygiene conditions are among scenes reported by some public health care staff as Hong Kong struggles with its worst coronavirus outbreak to date. The Post talked to health care workers who shared their distressing experiences at public hospitals amid the fifth wave, along with their frustrations at being unable to provide proper care to so many patients.
"He wanted me to rent a one-bedroom in our apartment complex while he tried to figure out if he wanted to remain married."View Entire Post ›
Most schools, in the opinion of one expert consulted by Yahoo Life, will eventually end mask mandates, adding that recent CDC guidance gives them the ability to do so with confidence.
According to a study by Tulane University researchers, the grape compounds in the beverage can reduce blood sugar levels linked with the health condition.
NAMI Rochester's Mental Health Open Mic takes place on March 16th from 6:30p.m to 8 p.m. at Happy Gut Sanctuary.
A state regulatory board for the first time has suspended the license of a Twin Cities plastic surgeon who has been repeatedly accused of molesting female clients during appointments spanning years. The Minnesota Board of Medical Practice's temporary suspension of Dr. Christopher Kovanda's license took effect Thursday and will be the subject of a closed-door hearing in the coming weeks. Either …
UnsplashAt this point, we can safely confirm that booze is bad for the brain. The question on everyone’s mind, however, is how bad is it really? The vast majority of us leave binge drinking behind in college and our 20s. Surely knocking back a few drinks every week can’t really be that bad, right?Well… a new study run by University of Pennsylvania researchers found that even light-to-moderate levels of alcohol consumption, like one drink a day, was associated with overall reductions in brain vol


Add a Comment

Your email address will not be published. Required fields are marked *